Skip to main content
. Author manuscript; available in PMC: 2022 Jan 21.
Published in final edited form as: Nat Rev Cardiol. 2020 Mar 26;17(8):503–522. doi: 10.1038/s41569-020-0347-2

Fig. 3 |. Risk of arterial thromboembolic events in patients with cancer.

Fig. 3 |

Outline of the risk of arterial thromboembolic events relative to the time of cancer diagnosis in patients in the US Medicare system. A vulnerable and high-risk period of arterial thromboembolic events can be defined as illustrated, particularly for the cancer types listed. Baseline risk factors and long-term risk dynamics remain to be defined. The plot was generated using data from REFS67,253. HR, hazard ratio; MI, myocardial infarction.